PRIVILEGED AND CONFIDENTIAL ATTORNEY-CLIENT COMMUNICATION — ATTORNEY WORK PRODUCT

PRIVILEGED AND CONFIDENTIAL ATTORNEY-CLIENT COMMUNICATION — ATTORNEY WORK PRODUCT
MEMORANDUM
August 2, 2023
FROM: Wendy Schultz, Senior Associate, intellectual Property Calderwood & Harkness LLP
TO: Catherine Bloom, Partner, intellectual Property (Responsible Partner) Alan Ngo, Partner, intellectual Property (Billing Partner) Daniel Oshiro, General Counsel, Brightfield Cloud Services Inc.
RE: Redline Analysis — Technology License Agreement (Draft 2) — Nexilis Innovations Ltd. Revisions to DeltaSync Platform License
MATTER NO.: 1042-00003
BILLING CODE: BCS-NEXILIS-LIC-2023
CC: Omar Siddiqui, Associate, intellectual Property, Calderwood & Harkness LLP
This memorandum is a privileged and confidential attorney-client communication and attorney work product. It is prepared solely for the use of the addressees identified above and contains the legal analysis, opinions, and recommendations of Calderwood & Harkness LLP. This memorandum should not be disclosed to any third party without the prior written consent of Calderwood & Harkness LLP and Brightfield Cloud Services Inc. Disclosure to any third party may result in a waiver of applicable privileges.
I. Executive Summary
On July 17, 2023, Calderwood & Harkness LLP, on behalf of Brightfield Cloud Services Inc. ("Brightfield" or the "Company"), delivered Draft 1 of the Technology License Agreement (the "License Agreement") to Whitmore & Falk LLP, counsel to Nexilis Innovations Ltd. ("Nexilis"). Draft 1 set forth the terms of an exclusive, worldwide, fully paid-up inbound license to the DeltaSync distributed-cache orchestration technology, including all associated intellectual property rights (collectively, the "DeltaSync Platform"), for integration into Brightfield's Stratos enterprise cloud-management platform (the "Stratos Platform").
On July 31, 2023, Whitmore & Falk LLP returned a redlined version of the License Agreement (the "Draft 2" or the "Nexilis Redline") containing significant revisions across multiple provisions of the agreement. This memorandum provides a comprehensive analysis of all material changes introduced in Draft 2, together with our legal assessment of each change and recommendations for Brightfield's negotiating posture going forward.
The most commercially significant revision introduced in Draft 2 is the insertion of a narrow field-of-use restriction in Section 2.1 of the License Agreement. Specifically, Nexilis has proposed limiting Brightfield's deployment of the DeltaSync technology solely to end-customers whose primary business activities fall within two industry verticals: (a) financial services, as classified under Standard Industrial Classification ("SIC") codes 6000 through 6799, and (b) healthcare services, as classified under SIC codes 8000 through 8099. This restriction was not present in Draft 1, which contemplated an unrestricted field of use across all enterprise software-as-a-service applications and cloud infrastructure deployments, without limitation as to industry vertical or end-customer sector.
Based on our analysis, the field-of-use restriction as drafted would confine Brightfield to approximately 26.8% of its total current addressable market, rendering the $8,000,000 aggregate license fee commercially difficult to justify. Beyond the field-of-use restriction, Draft 2 introduces several other material changes — including an aggregate cap on intellectual property indemnification, new sublicensing restrictions, audit rights tied to field-of-use compliance, a licensor termination-for-convenience right, and anti-assignment provisions covering change-of-control transactions — each of which requires careful attention and, in most cases, renegotiation.
Recommendation: The field-of-use restriction as drafted is commercially unacceptable to Brightfield and should be rejected or substantially renegotiated. Several other revisions introduced in Draft 2 also require significant modification before the License Agreement is acceptable to the Company. This memorandum sets forth our detailed analysis and recommendations for each material issue, together with proposed next steps for advancing negotiations with Nexilis and Whitmore & Falk LLP.
II. Background and Procedural Context
The following procedural history provides context for the redline analysis that follows.
Brightfield Cloud Services Inc. is a Delaware corporation headquartered in Austin, Texas, that develops and markets the Stratos enterprise cloud-management platform. Stratos is an industry-agnostic platform deployed across a broad range of customer verticals, including technology, telecommunications, government, manufacturing, financial services, healthcare, retail, and other sectors. As discussed further in Section IV.C below, Brightfield's FY2022 annual recurring revenue ("ARR") was approximately $142,000,000, distributed across these verticals.
Nexilis Innovations Ltd. is a Delaware corporation based in Cambridge, Massachusetts, that developed the DeltaSync distributed-cache orchestration technology. Nexilis is a venture-backed company; its lead Series B investor is Ridgeline Ventures, a venture capital firm with portfolio companies active in the enterprise software and cloud infrastructure markets. As discussed in Section IV.D below, Ridgeline's portfolio composition is relevant to the field-of-use analysis.
The key procedural milestones in this engagement are as follows:
•  June 8, 2023: Brightfield engaged Calderwood & Harkness LLP to represent it as licensee in negotiating an inbound exclusive technology license from Nexilis for the DeltaSync Platform. The engagement letter was executed by Daniel Oshiro, General Counsel of Brightfield, and Catherine Bloom, Partner, on behalf of Calderwood & Harkness.
•  June 19, 2023: Mutual Non-Disclosure Agreement between Brightfield and Nexilis was executed, governing the exchange of confidential information during the license negotiation. The NDA has a two-year term with standard carve-outs for publicly available information, independently developed information, and information received from third parties without restriction.
•  June 26, 2023: Crestline Patent Analytics LLC ("Crestline") was retained by Calderwood & Harkness (on behalf of Brightfield) to conduct a patent landscape and freedom-to-operate analysis with respect to the DeltaSync patent portfolio.
•  July 10, 2023: Crestline delivered its preliminary patent landscape memorandum. The Crestline analysis confirmed that the DeltaSync patent portfolio comprises fourteen (14) issued U.S. utility patents, numbered U.S. Patent Nos. 11,234,567 through 11,234,580, covering various aspects of distributed-cache orchestration, data-shard synchronization, and fault-tolerant data-replication protocols. The portfolio also includes six (6) pending U.S. patent applications, numbered App. Nos. 17/901,201 through 17/901,206, directed to next-generation improvements in the DeltaSync architecture. The Crestline preliminary analysis did not identify any material freedom-to-operate issues with respect to Brightfield's planned integration of DeltaSync into the Stratos Platform.
•  July 17, 2023: Draft 1 of the License Agreement was delivered by Calderwood & Harkness to Whitmore & Falk LLP, counsel to Nexilis, at 100 Federal Street, 28th Floor, Boston, MA 02110. Draft 1 reflected Brightfield's desired deal terms as discussed and approved by Daniel Oshiro and the Brightfield executive team, including an exclusive, worldwide, fully paid-up license with an unrestricted field of use, comprehensive IP indemnification by Nexilis, broad sublicensing rights, and standard protective provisions for the licensee.
•  July 31, 2023: Draft 2 (the Nexilis Redline) was received from Whitmore & Falk LLP via email transmission to the Calderwood & Harkness deal team. The redline was prepared by Jessica Whitmore, Partner, of Whitmore & Falk, and included a brief cover letter indicating that "our client has made revisions to reflect Nexilis's commercially reasonable expectations regarding the scope and conditions of the license grant."
The proposed aggregate license fee of $8,000,000, structured as $3,200,000 in upfront consideration payable at closing and $1,600,000 per year for three years in maintenance and support payments, was not altered in Draft 2. Similarly, the license term of five (5) years with a two (2)-year renewal option was retained without modification. The fact that Nexilis did not seek to alter the financial terms while simultaneously narrowing the scope of the license grant is noteworthy and reinforces the view that the field-of-use restriction is commercially imbalanced — Nexilis is seeking to retain the same price while materially reducing the scope of what Brightfield receives.
III. Summary of Material Changes in Draft 2
Overview.  Draft 2 contains revisions in approximately twenty-seven (27) sections of the License Agreement. For purposes of this memorandum, we have categorized the changes into three tiers:
•  (A) Critical / Deal-Level Changes — Revisions that fundamentally alter the commercial bargain or create material legal risk for Brightfield, requiring resolution before the transaction can proceed.
•  (B) Material but Negotiable Changes — Revisions that are commercially or legally significant but susceptible to compromise through targeted negotiation.
•  (C) Minor / Conforming Changes — Revisions that are administrative, conforming, or otherwise non-substantive in nature.
The following table summarizes the material changes introduced in Draft 2, organized by category and section reference:
Each of the Category A and Category B changes is analyzed in detail in Sections IV through VIII below. The Category C (Minor / Conforming) changes are addressed in Section IX.
IV. Critical Change: Field-of-Use Restriction (Section 2.1 — Grant of License)
The insertion of a narrow field-of-use restriction in Section 2.1 is the single most commercially significant change introduced in Draft 2. This section provides a detailed comparison of the Draft 1 and Draft 2 language, an analysis of the commercial impact on Brightfield, a legal analysis of the enforceability and competitive implications of the restriction, and our recommendation for Brightfield's negotiating posture.
A. Draft 1 (Brightfield's Position)
Section 2.1 of Draft 1, as prepared and delivered by Calderwood & Harkness on behalf of Brightfield, contained the following grant language:
"Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee an exclusive, worldwide, fully paid-up, irrevocable (except as expressly provided herein) license, under all of Licensor's rights in and to the Licensed Technology (including, without limitation, all Licensed Patents, Licensed Know-How, and Licensed Trade Secrets), to use, reproduce, modify, create derivative works of, distribute, display, perform, and otherwise exploit the Licensed Technology for integration into Licensee's 'Stratos' enterprise cloud-management platform and related products and services, in all enterprise software-as-a-service applications and related cloud infrastructure deployments, without limitation as to industry vertical or end-customer sector."
The breadth of this grant language was deliberate and was specifically discussed with and approved by Daniel Oshiro and the Brightfield executive team prior to delivery. The Stratos Platform is an industry-agnostic product. Its core value proposition — centralized management, optimization, and orchestration of multi-cloud and hybrid-cloud infrastructure — applies with equal force across all industry verticals. Brightfield's existing customer base spans technology, telecommunications, government, manufacturing, financial services, healthcare, retail, energy, logistics, and other sectors. The integration of DeltaSync's distributed-cache orchestration capabilities into Stratos is intended to enhance the platform's performance for all customers, not merely those in a particular vertical.
Accordingly, any field-of-use restriction that limits Brightfield's ability to deploy DeltaSync-enhanced Stratos functionality to only a subset of its customer base would undercut the fundamental commercial rationale for the license.
B. Draft 2 (Nexilis's Revisions)
Nexilis introduced four interrelated changes in Draft 2 that collectively implement the field-of-use restriction:
First, Nexilis inserted a new defined term in Section 1.1 of the Agreement:
Second, Nexilis revised the grant clause in Section 2.1 to limit the scope of the license:
"Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee an exclusive,   fully paid-up,   license, under all of Licensor's rights in and to the Licensed Technology (including, without limitation, all Licensed Patents, Licensed Know-How, and Licensed Trade Secrets), to use, reproduce, modify, create derivative works of, distribute, display, perform, and otherwise exploit the Licensed Technology  for integration into Licensee's 'Stratos' enterprise cloud-management platform and related products and services."
Third, Nexilis added a new Section 2.1(c) — Reservation of Rights:
Fourth, Nexilis added a new affirmative covenant in Section 2.4:
Taken together, these four revisions transform the license from an exclusive, unrestricted grant covering all industry verticals into a narrowly circumscribed grant limited to two specific sectors — financial services and healthcare — while expressly preserving Nexilis's ability to license DeltaSync to third parties (including, potentially, Brightfield's competitors) in all other verticals.
C. Commercial Impact Analysis
The commercial impact of the proposed field-of-use restriction on Brightfield is severe. We have analyzed this impact using internal revenue segmentation data provided by Lisa Redmond, Vice President, Corporate Development & Strategy, Brightfield Cloud Services Inc.
Brightfield's FY2022 annual recurring revenue ("ARR") was approximately $142,000,000 in the aggregate. Based on the segmentation data provided by Ms. Redmond, this revenue is distributed across industry verticals as follows:
As the table makes clear, the "Permitted Field" — financial services and healthcare combined — represents approximately $38,000,000 in ARR, or only approximately 26.8% of Brightfield's total current revenue base. The remaining approximately $104,000,000 in ARR (approximately 73.2%) is generated from customers in industry verticals that would fall outside the Permitted Field.
Accepting the narrow field-of-use restriction would therefore restrict Brightfield's ability to deploy DeltaSync-enhanced Stratos functionality to roughly one-quarter of its existing customer base. Moreover, because the Stratos Platform's addressable market continues to expand — Brightfield's FY2023 revenue target reflects anticipated growth across all verticals, including technology and telecommunications — the proportion of the total addressable market foreclosed by the Permitted Field restriction would likely increase over time as Brightfield's non-financial-services and non-healthcare revenues grow.
Return-on-Investment Impact. At an aggregate license fee of $8,000,000, the proposed restriction would require Brightfield to pay $8,000,000 for the right to enhance only approximately $38,000,000 in addressable ARR (an implied license-cost-to-addressable-ARR ratio of approximately 21%). Under Draft 1's unrestricted field of use, the same $8,000,000 investment would address the Company's entire $142,000,000+ ARR base (an implied ratio of approximately 5.6%). The nearly four-fold increase in the effective cost ratio renders the deal commercially unattractive at the current price point.
Operational Complexity. Beyond the revenue impact, the field-of-use restriction would impose significant operational burdens on Brightfield's engineering and product teams. Because the Stratos Platform is a single, unified product — not a collection of vertical-specific offerings — compliance with the Permitted Field restriction would require Brightfield to either (a) maintain separate product builds with DeltaSync-integrated features for financial services and healthcare customers and non-integrated builds for all other customers, or (b) implement feature-gating mechanisms within the unified product that activate or deactivate DeltaSync functionality based on the industry classification of each customer. Either approach would increase engineering costs, introduce product complexity, create inconsistencies in the customer experience, and add ongoing maintenance overhead. Based on preliminary estimates from Brightfield's engineering leadership, the cost of implementing and maintaining such feature-gating could range from $1,200,000 to $2,000,000 annually, further eroding the return on the license investment.
Competitive Risk. The Reservation of Rights provision in Section 2.1(c) expressly preserves Nexilis's ability to license DeltaSync to third parties outside the Permitted Field. This means that Nexilis could license the same technology to one or more of Brightfield's direct competitors — including, for example, CloudStrux Inc. or Avalon Mesh Technologies — for deployment in technology, telecommunications, government, manufacturing, and other verticals where Brightfield generates the majority of its revenue. Such competing deployments would not only negate Brightfield's competitive advantage from the DeltaSync integration but could actively harm Brightfield's competitive position by enabling rivals to offer equivalent or superior cache-orchestration capabilities in Brightfield's most important markets.
D. Legal Analysis of the Field-of-Use Restriction
Enforceability Under Patent Law. As a threshold matter, field-of-use restrictions in patent licenses are generally enforceable under U.S. patent law. The Supreme Court's decision in General Talking Pictures Corp. v. Western Electric Co., 304 U.S. 175 (1938), established that a patentee may lawfully limit a license grant to a particular field of use and that a licensee who exceeds the scope of such a restriction is liable for patent infringement. This principle has been consistently reaffirmed by the Federal Circuit, including in Monsanto Co. v. McFarling, 363 F.3d 1336 (Fed. Cir. 2004), and TransCore, LP v. Electronic Transaction Consultants Corp., 563 F.3d 1271 (Fed. Cir. 2009). Accordingly, if Brightfield were to accept the Permitted Field restriction and subsequently deploy DeltaSync-integrated products to customers outside financial services and healthcare, Nexilis would likely have a viable claim for breach of contract and, potentially, patent infringement.
Antitrust Considerations. While field-of-use restrictions are generally permissible under patent law, they are not immune from antitrust scrutiny. Under Section 1 of the Sherman Act, 15 U.S.C. § 1, a license restriction may be challenged if it constitutes an unreasonable restraint of trade — for example, if it serves as a mechanism to allocate markets among competitors or to facilitate coordinated pricing behavior.
The field-of-use restriction proposed by Nexilis is potentially concerning from an antitrust perspective for the following reasons:
(i) Nexilis's Investor Relationships. Nexilis's lead Series B investor is Ridgeline Ventures. Ridgeline's publicly disclosed portfolio includes at least three enterprise software companies that compete, directly or indirectly, with Brightfield in non-financial-services and non-healthcare verticals — specifically, CloudStrux Inc. (cloud infrastructure management for telecommunications carriers), Avalon Mesh Technologies (distributed computing solutions for government and defense), and TerraNode Systems (edge-computing platforms for manufacturing and logistics). If Nexilis intends to license DeltaSync to one or more of these Ridgeline portfolio companies in the verticals excluded from Brightfield's Permitted Field, the field-of-use restriction could function as a mechanism to allocate the enterprise cloud-management market among affiliated entities, with each Ridgeline-associated licensee receiving a distinct vertical.
(ii) Exclusivity Within the Permitted Field. Notably, the license granted to Brightfield under Draft 2 remains exclusive within the Permitted Field (financial services and healthcare). This means that the overall structure contemplated by Nexilis may involve granting exclusive vertical-specific licenses to multiple licensees — each of which may be a Ridgeline portfolio company or affiliate. Such a hub-and-spoke licensing arrangement, coordinated through a common investor (Ridgeline), could raise serious concerns under Section 1 of the Sherman Act if it has the purpose or effect of allocating customers or markets among horizontal competitors.
(iii) Brightfield's Market Position. The Stratos Platform is a leading enterprise cloud-management solution with a significant installed base across multiple verticals. Restricting Brightfield's access to DeltaSync technology in its largest revenue-generating verticals (technology and telecommunications), while enabling Brightfield's competitors to deploy the same technology in those verticals, would have a direct and material competitive impact.
We do not suggest that these antitrust concerns are dispositive, and a full antitrust analysis would require additional factual investigation (including an understanding of Nexilis's existing and contemplated licensing arrangements outside the Permitted Field). However, these considerations provide additional leverage for Brightfield in negotiating against the field-of-use restriction, and Brightfield may wish to raise them in discussions with Whitmore & Falk.
Brightfield should consider requesting disclosure of any existing or contemplated licenses that Nexilis has granted or intends to grant in non-Permitted-Field verticals. Such disclosure would allow Brightfield and Calderwood & Harkness to assess whether the field-of-use restriction is part of a broader market-allocation strategy and to evaluate the antitrust risk profile of the proposed arrangement more fully.
E. Recommendation.  Based on the foregoing commercial and legal analysis, our recommendation with respect to the field-of-use restriction is as follows:
1.  Primary Position: Reject the narrow field-of-use restriction as drafted. Brightfield should firmly communicate to Nexilis that the Permitted Field restriction is commercially unacceptable. The restriction would confine Brightfield to approximately one-quarter of its addressable market, render the $8,000,000 license fee unjustifiable from a return-on-investment standpoint, impose substantial operational complexity and engineering costs, and expose Brightfield to competitive harm from third-party licenses in excluded verticals.
2.  First Alternative: Unrestricted field of use at the agreed $8,000,000 aggregate fee. Brightfield's preferred outcome is a return to the Draft 1 language — an exclusive, worldwide license without limitation as to industry vertical or end-customer sector. Given that the $8,000,000 fee was negotiated on the premise of an unrestricted field of use, Brightfield should argue that this is the economically appropriate scope for the agreed price.
3.  Second Alternative: Tiered or expandable field-of-use structure with corresponding fee adjustments. If Nexilis is unwilling to grant a fully unrestricted field of use, Brightfield should propose a tiered structure under which the initial Permitted Field includes financial services, healthcare, and technology (Brightfield's three largest verticals, representing approximately 49.0% of ARR), with options to expand the field of use to additional verticals upon payment of incremental fees. Any such structure should include pre-agreed pricing for each expansion vertical and a "most favored licensee" clause ensuring that Brightfield receives terms no less favorable than those granted to any other licensee.
4.  Fallback Position: If Nexilis is entirely unwilling to negotiate on the field-of-use restriction, Brightfield should evaluate whether the deal remains commercially viable. At a minimum, if a narrow field of use is to be accepted, the aggregate license fee must be substantially reduced to reflect the diminished scope of the grant — we would recommend a reduction to no more than $2,500,000 to $3,000,000 in aggregate fees for a two-vertical Permitted Field.
V. Material Change: IP Indemnification Cap (Section 9.2 — Indemnification by Licensor)
A. Draft 1 Position
Section 9.2 of Draft 1, as prepared by Calderwood & Harkness, required Nexilis to indemnify, defend, and hold harmless Brightfield and its affiliates, officers, directors, employees, and agents (collectively, the "Licensee Indemnitees") against all third-party claims, actions, suits, or proceedings alleging that Brightfield's use, reproduction, modification, distribution, or other exploitation of the DeltaSync Platform within the scope of the license infringes or misappropriates any third-party intellectual property right, including any patent, copyright, trademark, trade secret, or other proprietary right (each, an "IP Infringement Claim"). Nexilis's indemnification obligation under Draft 1 encompassed all damages, judgments, settlements, and reasonable attorneys' fees and costs incurred by any Licensee Indemnitee in connection with any IP Infringement Claim.
Critically, the indemnification obligation in Draft 1 was uncapped — that is, there was no aggregate monetary limit on Nexilis's liability under Section 9.2. This was a deliberate and commercially important feature of the Draft 1 structure. Given that Brightfield is integrating the DeltaSync technology into its flagship Stratos Platform — a product that generates $142,000,000 in annual recurring revenue — the potential exposure from an IP infringement claim against the DeltaSync technology is substantial. An uncapped indemnification obligation reflects the allocation of risk appropriate for a transaction of this nature: Nexilis, as the owner and developer of the technology, is in the best position to assess and bear the risk of third-party IP claims, while Brightfield, as the licensee, has limited ability to independently evaluate the IP landscape surrounding technology it did not develop.
B. Draft 2 Revisions
Nexilis introduced four changes to the IP indemnification provision in Draft 2:
(i) Aggregate Cap. Nexilis inserted an aggregate cap on its IP indemnification liability equal to "the total License Fees actually paid by Licensee to Licensor as of the date on which the applicable IP Infringement Claim is first asserted against any Licensee Indemnitee." Under this formulation, the cap would initially be $3,200,000 (the upfront fee) and would increase over time as maintenance payments are made, reaching a maximum of $8,000,000 only after all fees are fully paid. This is a significant reduction from the uncapped obligation in Draft 1.
(ii) Combination Carve-Out. Nexilis added a carve-out excluding from the scope of Nexilis's indemnification obligation any IP Infringement Claim that arises from (a) any modification of the DeltaSync technology made by Brightfield or its sublicensees, or (b) the combination of the DeltaSync technology with any non-Nexilis technology, product, or service (the "Combination Carve-Out"). The Combination Carve-Out provides that Nexilis shall have no obligation to defend, indemnify, or hold harmless any Licensee Indemnitee with respect to any IP Infringement Claim to the extent such claim would not have arisen but for such modification or combination.
(iii) Notice Requirement. Nexilis added a requirement that Brightfield provide "prompt written notice" of any IP Infringement Claim, specified as "not later than ten (10) business days following the date on which any Licensee Indemnitee first becomes aware of such claim." Nexilis further provided that the failure to provide timely notice shall relieve Nexilis of its indemnification obligation "to the extent that Licensor is materially prejudiced by such failure."
(iv) Right-to-Cure Alternatives. Nexilis reserved the right, as an alternative to defending and indemnifying Brightfield against an IP Infringement Claim, to at its sole option: (a) procure for Brightfield the right to continue using the DeltaSync technology; (b) modify the DeltaSync technology to render it non-infringing while maintaining substantially equivalent functionality; or (c) terminate the License Agreement and refund to Brightfield a "pro-rata portion of unearned License Fees." The pro-rata refund formula was not defined with specificity.
C. Analysis and Recommendation
Aggregate Cap. The aggregate cap tied to fees actually paid as of the date of the claim is below market for a technology license of this magnitude. Based on our review of comparable transactions in the enterprise software and cloud-infrastructure sectors, the typical market practice is to cap IP indemnification at 1.5× to 2.0× the aggregate license fees payable under the agreement (i.e., $12,000,000 to $16,000,000 in this case). Moreover, tying the cap to fees "actually paid" rather than fees "payable" creates a perverse incentive structure in which Nexilis's indemnification exposure is lowest at the beginning of the license term — precisely when Brightfield is most vulnerable, having committed to integration but not yet realized the full commercial benefits of the license. We recommend proposing a cap of 2.0× the aggregate license fees payable (i.e., $16,000,000), calculated on the full $8,000,000 aggregate fee regardless of the payment schedule.
Combination Carve-Out. Combination carve-outs are standard in technology license agreements and are generally acceptable in principle. However, the Combination Carve-Out as drafted in Draft 2 is overbroad in that it would exclude from Nexilis's indemnification obligation any claim arising from the integration of DeltaSync into the Stratos Platform — which is the very purpose of the license. Brightfield is acquiring the DeltaSync license specifically to integrate it into Stratos; a combination carve-out that negates Nexilis's indemnification obligation for the authorized integration would render the indemnification largely illusory. We recommend narrowing the Combination Carve-Out to exclude combinations and modifications that are (a) specifically contemplated or authorized by the License Agreement (i.e., integration into the Stratos Platform) and (b) performed in accordance with Nexilis's technical documentation and integration specifications.
Notice Requirement. The ten (10) business-day notice requirement is aggressive. IP infringement claims are often complex, and a licensee may require time to evaluate the claim, consult with counsel, and determine the appropriate course of action before providing formal notice to the licensor. We recommend negotiating for a thirty (30) calendar-day notice period, with the existing prejudice standard — i.e., Nexilis is relieved of its indemnification obligation only to the extent it is materially prejudiced by the delay in notice.
Right-to-Cure Alternatives. The right-to-cure alternatives (procure rights, modify, or terminate-and-refund) are generally standard in technology license agreements. However, the "pro-rata portion of unearned License Fees" refund formula in option (c) must be clearly defined to avoid disputes. We recommend specifying that the pro-rata refund shall be calculated on a straight-line amortization basis over the five-year license term — that is, the refund shall equal the total aggregate fees paid, less 1/60th of the aggregate fees for each full calendar month of the license term elapsed as of the termination date. Additionally, if Nexilis exercises the termination-and-refund option, Brightfield should receive a reasonable transition period (not less than twelve (12) months) to remove or replace the DeltaSync integration from the Stratos Platform.
Summary of IP Indemnification Recommendations:
VI. Material Change: Sublicensing Restrictions (Section 2.3 — Sublicense Rights)
A. Draft 1 Position
Section 2.3 of Draft 1 granted Brightfield broad sublicensing rights that reflected the realities of Brightfield's go-to-market strategy and operational model. Specifically, Draft 1 authorized Brightfield to sublicense the DeltaSync technology to:
(a) Affiliates of Brightfield (defined as any entity controlling, controlled by, or under common control with Brightfield) without the prior consent of Nexilis, for purposes of supporting the development, operation, and delivery of the Stratos Platform;
(b) Third-party service providers acting on Brightfield's behalf, including managed service providers, hosting partners, system integrators, and resellers, without the prior consent of Nexilis, to the extent reasonably necessary for such service providers to perform services in connection with the Stratos Platform; and
(c) End-customers of Brightfield, to the extent necessary for such end-customers to use and access the DeltaSync-integrated features and functionality of the Stratos Platform.
All sublicenses under Draft 1 were required to be consistent with the terms of the master License Agreement and to impose on each sublicensee obligations of confidentiality and IP protection no less restrictive than those imposed on Brightfield.
B. Draft 2 Revisions
Nexilis introduced several material restrictions on Brightfield's sublicensing rights in Draft 2:
(i) Third-Party Service Provider Sublicensing. Nexilis eliminated the right to sublicense to third-party service providers without prior written consent. Under Draft 2, Brightfield must obtain the prior written consent of Nexilis before granting any sublicense to any third-party service provider, managed service provider, hosting partner, system integrator, reseller, or other non-affiliate entity. The Draft 2 language does not include a "consent not to be unreasonably withheld" qualifier, leaving Nexilis with unfettered discretion to deny consent.
(ii) Affiliate Sublicensing. Draft 2 permits sublicenses to affiliates, but only for entities in which Brightfield holds a direct or indirect majority ownership interest (greater than 50% of the voting equity). This narrows the standard "control" definition used in Draft 1, which would have encompassed entities under common control with Brightfield (e.g., sister portfolio companies of Vantage Summit Capital Partners). Additionally, all affiliate sublicenses must be limited to activities within the Permitted Field.
(iii) End-Customer Sublicensing. Draft 2 limits end-customer sublicenses to a "use only" right — specifically, end-customers may use the DeltaSync-integrated features of the Stratos Platform solely in the manner made available by Brightfield but may not access, modify, reverse-engineer, decompile, or disassemble any DeltaSync components. This is more restrictive than Draft 1, which did not include the explicit reverse-engineering prohibition at the sublicense level (though the master agreement contained such prohibitions).
(iv) Flow-Down Requirements. All sublicenses must incorporate terms no less protective of Nexilis's intellectual property rights than the terms of the master License Agreement. This is substantially consistent with Draft 1, though Draft 2 adds a requirement that sublicense agreements expressly name Nexilis as a third-party beneficiary with independent enforcement rights.
(v) Reporting Obligation. Nexilis added a new requirement that Brightfield provide quarterly reports to Nexilis listing all active sublicensees, including the name, address, and nature of each sublicensee and a description of the scope and purpose of each sublicense grant.
C. Analysis and Recommendation
Third-Party Service Provider Sublicensing. The restriction on third-party service provider sublicensing is the most problematic of the Draft 2 sublicensing revisions. Brightfield's go-to-market model for the Stratos Platform relies significantly on channel partners, managed service providers, and system integrators. Approximately 35% of Brightfield's customer deployments are supported by third-party service providers who require some degree of sublicense rights in order to deploy, configure, and manage the Stratos Platform on behalf of Brightfield's end-customers. Requiring Nexilis's prior written consent for each such sublicense — particularly without a "not unreasonably withheld" qualifier — would create unacceptable operational bottlenecks and introduce deal-level uncertainty for Brightfield's channel partnerships.
We recommend negotiating for the following structure:
(a) Pre-approved categories of sublicensees — specifically, hosting partners, managed service providers, system integrators, and value-added resellers — that may receive sublicenses without requiring case-by-case consent from Nexilis, provided that such sublicensees agree to the flow-down terms required by the License Agreement;
(b) For all other categories of third-party sublicensees, Nexilis's consent shall be required but shall not be unreasonably withheld, conditioned, or delayed, and shall be deemed granted if Nexilis does not respond within fifteen (15) business days of Brightfield's written request.
Affiliate Sublicensing. The majority-ownership threshold (greater than 50%) is generally acceptable and consistent with market practice for affiliate sublicensing in technology license agreements. The limitation to the Permitted Field is, of course, objectionable to the extent the Permitted Field restriction itself is objectionable (see Section IV above). We recommend accepting the majority-ownership threshold but deleting the Permitted Field limitation in the sublicensing context, consistent with our primary position on the field-of-use restriction.
End-Customer Sublicensing. The "use only" limitation and the explicit prohibition on reverse-engineering, decompilation, and disassembly at the end-customer sublicense level are generally reasonable and consistent with industry practice for SaaS deployments. These provisions protect Nexilis's proprietary technology while allowing end-customers to use the DeltaSync-integrated features of Stratos in the ordinary course. We recommend accepting these provisions with minor clarifying edits.
Third-Party Beneficiary Designation. The requirement that sublicense agreements name Nexilis as a third-party beneficiary with independent enforcement rights is more aggressive than typical practice and could expose Brightfield and its sublicensees to direct claims by Nexilis. We recommend limiting Nexilis's third-party beneficiary rights to enforcement of the IP protection and confidentiality provisions of the sublicense (not the full agreement) and requiring that Nexilis provide written notice to Brightfield and a reasonable opportunity to cure before pursuing enforcement directly against a sublicensee.
Reporting Obligation. Quarterly reporting of all active sublicensees is administratively burdensome, particularly given Brightfield's large and dynamic channel partner network. We recommend negotiating for semi-annual reporting (i.e., twice per year) and limiting the reporting obligation to sublicensees that receive rights beyond the standard "use only" end-customer sublicense (i.e., reporting should be required for hosting partners, managed service providers, and other parties that receive deployment-level access to DeltaSync components, but not for ordinary end-customers).
VII. Material Change: Audit Rights (New Section 7.5)
A. Draft 1 Position
Draft 1 of the License Agreement did not include any audit rights for either party. This was consistent with the fully paid-up fee structure of the license — because Brightfield's obligation to pay license fees is fixed and does not depend on usage, revenue, or royalty calculations, there is no financial metric that would require verification through an audit. Audit rights are a standard feature of royalty-bearing licenses, where the licensor has a legitimate interest in verifying the accuracy of the licensee's royalty calculations and payments, but they are unusual and generally unnecessary in fully paid-up license structures.
B. Draft 2 Revisions
Nexilis inserted a new Section 7.5 in Draft 2 granting Nexilis the right to audit Brightfield's use of the DeltaSync technology. The stated purpose of the audit right is to verify Brightfield's compliance with the Permitted Field restriction (Section 2.1) and the sublicensing limitations (Section 2.3). The key terms of the audit provision are as follows:
(i) Frequency. Nexilis may conduct audits up to two (2) times per calendar year.
(ii) Notice. Each audit requires not less than fifteen (15) business days' prior written notice to Brightfield.
(iii) Auditor. Audits are to be conducted by an independent third-party auditor selected by Nexilis and reasonably acceptable to Brightfield. The auditor must execute a confidentiality agreement with Brightfield prior to commencing the audit.
(iv) Scope of Access. Brightfield is required to provide the auditor with reasonable access to relevant systems, records, documentation, and customer lists to the extent necessary to verify compliance with the Permitted Field restriction and sublicensing limitations.
(v) Cost Allocation. Audits are to be conducted at Nexilis's expense, unless the audit reveals a material breach of the Permitted Field restriction or sublicensing limitations, in which case Brightfield shall bear the reasonable costs of the audit.
(vi) Reporting. Audit findings are to be shared with Nexilis in summary form only. Detailed customer data, including customer names, contract terms, and revenue data, is to remain confidential with the auditor and shall not be disclosed to Nexilis.
C. Analysis and Recommendation
The audit provision in Draft 2 is unusual for a fully paid-up license and is a direct consequence of the field-of-use restriction. If the field-of-use restriction were eliminated or substantially broadened, the audit provision would become largely unnecessary, as there would be no field-of-use compliance to verify. Accordingly, our primary recommendation is that the audit provision should be deleted if the field-of-use restriction is eliminated.
If, however, the field-of-use restriction remains in some form following negotiation, Brightfield should accept a limited audit right subject to the following modifications:
(a) Frequency. Reduce from twice per calendar year to once per calendar year. Annual audits provide adequate compliance oversight without imposing an unreasonable administrative burden on Brightfield's operations.
(b) Notice Period. The fifteen (15) business-day notice period is acceptable and does not require modification.
(c) Cost Allocation. The cost-shifting provision — under which Brightfield bears audit costs if a material breach is discovered — is standard in royalty-bearing licenses but is less appropriate in a fully paid-up context. We recommend that Nexilis bear the cost of all audits regardless of outcome, or, alternatively, that the cost-shifting provision apply only if the audit reveals a breach that is both material and willful.
(d) Confidentiality and Customer Data. The provision that detailed customer data remains confidential with the auditor and is not disclosed directly to Nexilis is a necessary baseline protection but should be strengthened. Specifically, the confidentiality agreement between the auditor and Brightfield should (i) prohibit the auditor from disclosing any customer-identifying information to Nexilis, even in summary form; (ii) require the auditor to report findings solely in terms of compliance or non-compliance, without identifying specific customers, contracts, or revenue figures; (iii) require the auditor to destroy or return all Brightfield materials within thirty (30) days of completing the audit; and (iv) provide that any breach of the confidentiality agreement by the auditor shall be deemed a breach by Nexilis under the License Agreement.
(e) Competitive Sensitivity. Access to Brightfield's customer lists and deployment records raises significant competitive sensitivity concerns. Nexilis, as a potential licensor of DeltaSync to Brightfield's competitors in non-Permitted-Field verticals, could exploit customer information obtained through the audit process. The confidentiality protections described above are essential to mitigate this risk.
VIII. Other Notable Changes (Material but Negotiable)
A. Representations and Warranties (Sections 8.1–8.6)
Draft 2 introduces three significant changes to Nexilis's representations and warranties regarding the DeltaSync patent portfolio and licensed technology:
Narrowed Knowledge Qualifier. In Draft 1, Nexilis represented that, "to the best of Licensor's knowledge," the Licensed Technology does not infringe any third-party intellectual property rights. In Draft 2, Nexilis has revised this qualifier to "to the actual knowledge of Dr. Eoin Callahan, Chief Scientist of Licensor." This change narrows the knowledge qualifier from an entity-level representation — which would impute to Nexilis the knowledge of all officers, directors, and senior employees — to a representation limited to the actual (not constructive) knowledge of a single individual. Dr. Callahan is Nexilis's Chief Scientist and the lead inventor on the majority of the DeltaSync patents, but he is not the only individual within Nexilis with knowledge of the IP landscape. Limiting the knowledge qualifier to Dr. Callahan alone creates a significant gap in the scope of the representation.
Recommendation: Broaden the knowledge qualifier to include the actual knowledge of at least four individuals: (i) Dr. Eoin Callahan, Chief Scientist; (ii) Dr. Samira Hajjar, Chief Executive Officer; (iii) Nathan Woolsey, General Counsel; and (iv) Rebekah Tran, Vice President, Business Development & Licensing. These individuals collectively have the most comprehensive understanding of the DeltaSync IP portfolio, Nexilis's freedom-to-operate position, and any third-party claims or inquiries that may bear on the non-infringement representation.
Deletion of Trade-Secret Non-Infringement Representation. Draft 1 included a representation by Nexilis that the DeltaSync technology does not, to the best of Licensor's knowledge, misappropriate any third-party trade secrets. Draft 2 deletes this representation entirely. The deletion is concerning because trade-secret misappropriation claims — particularly claims related to the hiring of former employees of competing technology companies — are a significant and growing source of IP risk in the enterprise software sector. Without this representation, Brightfield would have no contractual recourse against Nexilis if it were later discovered that elements of the DeltaSync technology were developed using misappropriated trade secrets.
Recommendation: Restore the trade-secret non-infringement representation, subject to the broadened knowledge qualifier described above. This is a standard and commercially reasonable representation in technology licenses.
Pending-Application Disclaimer. Nexilis added a disclaimer in Section 8.5 stating that Nexilis makes no representation or warranty that any of the six pending patent applications (App. Nos. 17/901,201 through 17/901,206) will issue as a patent or that any claims in such applications will be allowed in the form currently pending. This disclaimer is reasonable — the outcome of patent prosecution is inherently uncertain, and Nexilis cannot guarantee that the Patent and Trademark Office will allow any particular claim. We recommend accepting this disclaimer without modification.
B. Termination Provisions (Section 12)
Draft 2 introduces two significant changes to the termination provisions:
Licensor Termination for Convenience. Nexilis added a new Section 12.1(b) granting Nexilis the right to terminate the License Agreement for convenience upon one hundred eighty (180) days' prior written notice to Brightfield. Upon such termination, Nexilis would refund to Brightfield a pro-rata portion of unearned maintenance and support fees, but expressly would not refund any portion of the $3,200,000 upfront license fee. This provision is commercially unacceptable to Brightfield. The Company is making a significant upfront investment — not only the $3,200,000 license fee but also substantial internal engineering costs to integrate DeltaSync into the Stratos Platform — that cannot be recovered if the license is terminated at Nexilis's sole discretion. A termination-for-convenience right in favor of the licensor is inconsistent with the economic structure of a fully paid-up exclusive license and is atypical in comparable transactions.
Recommendation: Reject the licensor termination-for-convenience right. If Nexilis insists on retaining this right, Brightfield should negotiate for the following protections: (i) upon any termination for convenience by Nexilis, Nexilis shall refund all license fees and maintenance fees previously paid by Brightfield, including the full $3,200,000 upfront fee; and (ii) upon termination for convenience, Brightfield shall retain a perpetual, irrevocable, non-exclusive, royalty-free license to use, reproduce, and distribute the DeltaSync technology as integrated into the Stratos Platform as of the effective date of termination, without the right to develop further derivative works but with the right to maintain and update existing integrations.
Shortened Cure Period. Nexilis shortened the cure period for material breach from sixty (60) days in Draft 1 to thirty (30) days in Draft 2. Depending on the nature of the breach, thirty days may be insufficient for Brightfield to investigate and cure, particularly for complex technical or operational issues (e.g., a dispute over whether a particular customer falls within the Permitted Field based on its SIC code classification).
Recommendation: Restore the sixty (60)-day cure period. As a compromise, Brightfield would accept forty-five (45) days if necessary.
C. Assignment Restrictions (Section 14.3)
Draft 2 introduces a blanket prohibition on assignment by Brightfield without the prior written consent of Nexilis. Critically, this prohibition extends to assignments in connection with a change of control, merger, acquisition, or sale of all or substantially all of Brightfield's assets. Draft 1 had included a standard carve-out permitting assignment without consent in connection with such transactions, reflecting the widely accepted principle that a license should follow the business to which it relates in the context of a corporate transaction.
This change is of particular concern given Brightfield's status as a portfolio company of Vantage Summit Capital Partners, LP ("Vantage Summit"). Vantage Summit is a private equity firm that may seek a future exit from its investment in Brightfield via sale, merger, or initial public offering. An anti-assignment provision that requires Nexilis's consent for any change-of-control transaction could impede or delay a future exit, reduce the attractiveness of Brightfield to potential acquirers, and create transactional uncertainty.
Recommendation: Restore the change-of-control carve-out from Draft 1. The License Agreement should expressly permit assignment by Brightfield, without the prior consent of Nexilis, in connection with (i) a merger, consolidation, or other business combination involving Brightfield; (ii) a sale of all or substantially all of the assets of Brightfield or of the business unit to which the License Agreement relates; or (iii) a change of control of Brightfield (whether by sale of equity, tender offer, or otherwise). Brightfield should agree to provide Nexilis with prompt written notice of any such transaction and to ensure that the assignee agrees in writing to be bound by the terms of the License Agreement.
D. Limitation of Liability (Section 10)
Nexilis inserted a mutual limitation of liability provision capping each party's aggregate liability under the License Agreement at an amount equal to one times (1×) the aggregate license fees paid or payable under the agreement (i.e., $8,000,000). The cap is subject to express carve-outs for (i) liability arising from IP indemnification obligations under Section 9.2, (ii) liability arising from willful misconduct or fraud, and (iii) liability for breach of confidentiality obligations under Section 11.
Draft 1 did not include a general limitation of liability. While the absence of a liability cap is favorable to Brightfield as licensee, a mutual cap at 1× the aggregate fees is within the range of market practice for technology licenses of this magnitude and is not inherently unreasonable.
Recommendation: The cap amount of $8,000,000 is acceptable in principle. However, Brightfield should confirm and insist that the following items are fully carved out from the cap and not subject to any aggregate limitation:
(a) IP indemnification obligations under Section 9.2 (which should be subject to its own, higher cap as discussed in Section V above);
(b) Willful misconduct and fraud;
(c) Breach of confidentiality obligations;
(d) Nexilis's obligation to refund fees upon termination for convenience (if the termination-for-convenience right is retained); and
(e) Any liability arising from Nexilis's breach of the exclusivity grant or unauthorized licensing of DeltaSync to third parties within the Permitted Field — i.e., if Nexilis were to grant a conflicting license to a competitor of Brightfield within financial services or healthcare, the resulting liability should not be capped at $8,000,000 but should be uncapped or subject to a significantly higher limit.
IX. Minor / Conforming Changes
Draft 2 includes several additional changes that are administrative, conforming, or otherwise non-substantive in nature. These changes do not raise significant commercial or legal concerns, and we do not recommend that Brightfield expend negotiating capital on them. They are noted here for completeness:
Entity Details and Notice Address. Nexilis updated its entity details and notice address in the preamble and Section 15.1 (Notices) of the Agreement. The updated address is: 77 Kendall Square, Suite 400, Cambridge, MA 02139. This appears to reflect a recent office relocation and is consistent with publicly available information regarding Nexilis's current principal place of business.
Defined Term Adjustments. Several defined terms were adjusted for consistency and completeness. Most notably, the defined term "Licensed Technology" was expanded to include "Licensed Know-How" (defined as non-patented technical information, data, and specifications relating to the DeltaSync Platform) and "Licensed Trade Secrets" (defined as trade secrets as defined under the Delaware Uniform Trade Secrets Act, 6 Del. C. § 2001 et seq.), in addition to "Licensed Patents." These additions are consistent with the scope of the license grant in Draft 1 and do not represent a substantive change.
Boilerplate Provisions. Draft 2 includes minor wording adjustments to the merger/integration clause (Section 15.8), counterparts provision (Section 15.9), and waiver provision (Section 15.4). None of these adjustments alter the substance of the provisions. The governing law provision (Section 15.1) remains unchanged — the agreement continues to be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict-of-laws principles.
X. Summary of Recommendations and Proposed Next Steps
A. Recommendations Table
The following table summarizes our recommendations with respect to each material issue identified in Draft 2, together with the priority level and suggested negotiating fallback for each issue:
B. Proposed Next Steps
Based on the foregoing analysis, we recommend the following next steps:
1.  Internal Strategy Call. Schedule a call at the earliest opportunity with Daniel Oshiro (General Counsel, Brightfield), Lisa Redmond (VP Corporate Development & Strategy, Brightfield), and Marcus Vail (VP Engineering, Brightfield) to discuss the commercial priorities outlined in this memorandum and to confirm Brightfield's acceptable fallback positions on each material issue. In particular, we need guidance from Ms. Redmond on whether the tiered/expandable FOU alternative is commercially workable and from Mr. Vail on the estimated engineering costs of feature-gating if a narrow FOU is accepted.
2.  Prepare Draft 3 (Counter-Proposal). Following the internal strategy call, Calderwood & Harkness will prepare a revised License Agreement (Draft 3) incorporating Brightfield's counter-proposals on each material issue. Our target is to deliver Draft 3 to Whitmore & Falk LLP by mid-August 2023 (on or about August 18, 2023), in order to maintain negotiation momentum and position the parties for potential execution by end of Q3 2023.
3.  Separate Field-of-Use Term Sheet. Given the centrality of the field-of-use issue to the overall deal, we recommend considering the preparation of a separate field-of-use term sheet to isolate and negotiate the FOU issue independently from the balance of the agreement. This approach would allow the parties to reach agreement on the FOU scope and pricing before proceeding to finalize the remaining agreement terms, reducing the risk that the FOU dispute delays resolution of other negotiating points.
4.  Investor Coordination. Catherine Bloom should discuss the overall negotiation strategy with Graham Hollister at Vantage Summit Capital Partners, LP, given the potential implications of the field-of-use restriction and the anti-assignment provision for Brightfield's portfolio positioning and future exit options. Mr. Hollister's input on acceptable FOU scope, pricing, and change-of-control protections will be critical to ensuring alignment between Brightfield's management and its principal investor.
5.  Antitrust Diligence. We recommend that Brightfield request, through Whitmore & Falk, disclosure of any existing or contemplated licenses that Nexilis has granted or intends to grant for the DeltaSync technology outside the Permitted Field. If Nexilis declines to provide this information voluntarily, Brightfield may wish to include a representation in the License Agreement requiring Nexilis to disclose all third-party license grants and to covenant that it will not grant licenses to specified competitors of Brightfield without prior notice.
6.  Crestline Update. We recommend instructing Crestline Patent Analytics LLC to supplement its preliminary patent landscape memorandum with an analysis of the six pending patent applications (App. Nos. 17/901,201 through 17/901,206), including an assessment of the likelihood of issuance and the expected claim scope. This analysis will be relevant to Brightfield's evaluation of the pending-application disclaimer added by Nexilis in Section 8.5.
We are available to discuss this memorandum and the recommended next steps at the convenience of the addressees. Please do not hesitate to contact me directly at (212) 555-4820 or wschultz@calderwoodharkness.com.
Respectfully submitted,
CALDERWOOD & HARKNESS LLP
By: ________
Wendy Schultz Senior Associate, intellectual Property Calderwood & Harkness LLP
XI. Appendices
Appendix A — Redline Markup (Draft 1 vs. Draft 2)
The complete redline comparison of Draft 1 (Brightfield/Calderwood & Harkness, dated July 17, 2023) against Draft 2 (Nexilis/Whitmore & Falk, dated July 31, 2023) is maintained as a separate document and is available upon request. The redline was prepared using Microsoft Word's Track Changes functionality and reflects all insertions, deletions, and formatting changes introduced by Nexilis and Whitmore & Falk in Draft 2. The redline document has been uploaded to the Calderwood & Harkness matter management system under Matt